The current ACRS market cap is 81.56M. The company's latest EPS is USD -1.2253 and P/E is -0.94.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 19.02M | 7.75M | 2.53M | 1.87M | 9.28M |
Operating Income | -18.67M | -21.98M | -30.72M | -33.32M | -29.88M |
Net Income | -19.95M | -27.64M | -28.16M | -29.57M | -29.26M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 10.09M | 4.23M | 6.48M | 6.76M | 29.75M |
Operating Income | -135.41M | -111.06M | -50.91M | -65.38M | -85.15M |
Net Income | -132.74M | -161.35M | -51.02M | -90.87M | -86.91M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 267.63M | 254.6M | 229.71M | 235.65M | 218.35M |
Total Liabilities | 47.79M | 56.98M | 52.9M | 55.9M | 62.02M |
Total Equity | 219.84M | 197.62M | 176.81M | 179.75M | 156.33M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 275.57M | 98.3M | 70.78M | 251.21M | 254.6M |
Total Liabilities | 60.44M | 28.39M | 33.13M | 53.87M | 56.98M |
Total Equity | 215.12M | 69.91M | 37.65M | 197.34M | 197.62M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -48.45M | -67.57M | -26.35M | -47.01M | -71.56M |
Investing | 9.93M | 12.63M | 25.8M | 6.14M | 38.67M |
Financing | 72.83M | 72.87M | N/A | 26.74M | 26.66M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -100.81M | -96.45M | -38.63M | -52.13M | -67.57M |
Investing | 9.37M | 105.68M | 6.39M | -167.63M | 12.63M |
Financing | 128.26M | -30.32M | 18.37M | 225.05M | 72.87M |
Market Cap | 81.56M |
Price to Earnings Ratio | -0.94 |
Price to Sales Ratio | 2.74 |
Price to Cash Ratio | 1.8 |
Price to Book Ratio | 0.41 |
Dividend Yield | - |
Shares Outstanding | 70.93M |
Average Volume (1 week) | 1.17M |
Average Volume (1 Month) | 1.43M |
52 Week Change | -85.68% |
52 Week High | 11.12 |
52 Week Low | 0.5902 |
Spread (Intraday) | 0.07 (5.74%) |
Company Name | Aclaris Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.aclaristx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.